Xin Xu

6.7k total citations
118 papers, 2.9k citations indexed

About

Xin Xu is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Xin Xu has authored 118 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Oncology and 19 papers in Pharmacology. Recurrent topics in Xin Xu's work include Computational Drug Discovery Methods (18 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Analytical Chemistry and Chromatography (7 papers). Xin Xu is often cited by papers focused on Computational Drug Discovery Methods (18 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Analytical Chemistry and Chromatography (7 papers). Xin Xu collaborates with scholars based in United States, China and Canada. Xin Xu's co-authors include Yulia Vugmeyster, Pranav Shah, Amy Q. Wang, Huanghao Yang, Wei Zheng, Hao Lian, Guoming Huang, Ying Wu, Xiaoping Wu and Yan Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Xin Xu

117 papers receiving 2.9k citations

Peers

Xin Xu

ONCOL

IMMUN

Fang Bai China

Xiaodong Ma China

Ke Xia China

Li Tan China

Andrew M. Stern United States

Guangdi Wang United States

Yongmei Liu China

Zheng Yang United States

William R. Greco United States

Fang Bai China

Xin Xu

2.0k ×1.7

405 ×1.2

ONCOL

302 ×0.9

242 ×0.8

IMMUN

104 ×0.4

Citations per year, relative to Xin Xu Xin Xu (= 1×) peers Fang Bai

Countries citing papers authored by Xin Xu

Since Specialization

Citations

This map shows the geographic impact of Xin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Xu more than expected).

Fields of papers citing papers by Xin Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Xu. The network helps show where Xin Xu may publish in the future.

Co-authorship network of co-authors of Xin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Xu. A scholar is included among the top collaborators of Xin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Xu. Xin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Yi‐Han, Aleksandra Głogowska, Thatchawan Thanasupawat, et al.. (2025). The Brain-Penetrant Pan-ErbB Inhibitor Poziotinib Effectively Targets HER2+ Breast Cancer Brain Metastases. Cancer Research. 85(8). 1514–1529. 1 indexed citations

Shah, Pranav, Vishal B. Siramshetty, Ewy A. Mathé, & Xin Xu. (2024). Developing Robust Human Liver Microsomal Stability Prediction Models: Leveraging Inter-Species Correlation with Rat Data. Pharmaceutics. 16(10). 1257–1257. 1 indexed citations

Yasgar, Adam, Richard T. Eastman, Ruili Huang, et al.. (2023). Quantitative Bioactivity Signatures of Dietary Supplements and Natural Products. ACS Pharmacology & Translational Science. 6(5). 683–701. 2 indexed citations

Siramshetty, Vishal B., Xin Xu, & Pranav Shah. (2023). Artificial Intelligence in ADME Property Prediction. Methods in molecular biology. 2714. 307–327. 7 indexed citations

Padilha, Elias Carvalho, Mengbi Yang, Pranav Shah, et al.. (2023). In vitro and in vivo pharmacokinetic characterization, chiral conversion and PBPK scaling towards human PK simulation of S-MRI-1867, a drug candidate for Hermansky-Pudlak syndrome pulmonary fibrosis. Biomedicine & Pharmacotherapy. 168. 115178–115178. 3 indexed citations

Gross, Joshua, Yang Zhou, Daniel J. Jansen, et al.. (2022). Discovery of a functionally selective ghrelin receptor (GHSR _1a ) ligand for modulating brain dopamine. Proceedings of the National Academy of Sciences. 119(10). e2112397119–e2112397119. 10 indexed citations

Chen, Fannie W., Joanna P. Davies, Raul Calvo, et al.. (2022). Activation of mitochondrial TRAP1 stimulates mitochondria-lysosome crosstalk and correction of lysosomal dysfunction. iScience. 25(9). 104941–104941. 6 indexed citations

Wilson, Kenneth J., Courtney Myhr, Elena M. Kaftanovskaya, et al.. (2022). Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2. Communications Biology. 5(1). 1183–1183. 5 indexed citations

Williams, J. W., Vishal B. Siramshetty, Ðắc-Trung Nguyễn, et al.. (2022). Using in vitro ADME data for lead compound selection: An emphasis on PAMPA pH 5 permeability and oral bioavailability. Bioorganic & Medicinal Chemistry. 56. 116588–116588. 32 indexed citations

10.

Jiang, Yifan, Yichang Liu, Min Wang, et al.. (2021). siRNA-Based Carrier-Free System for Synergistic Chemo/Chemodynamic/RNAi Therapy of Drug-Resistant Tumors. ACS Applied Materials & Interfaces. 14(1). 361–372. 22 indexed citations

11.

Zhu, Hu, Olivia W. Lee, Pranav Shah, et al.. (2019). Identification of Activators of Human Fumarate Hydratase by Quantitative High-Throughput Screening. SLAS DISCOVERY. 25(1). 43–56. 5 indexed citations

12.

Yang, Shyh‐Ming, Natalia J. Martinez, Adam Yasgar, et al.. (2018). Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity. Journal of Medicinal Chemistry. 61(11). 4883–4903. 70 indexed citations

13.

Fromm, George, et al.. (2016). Gp96-Ig/Costimulator (OX40L, ICOSL, or 4-1BBL) Combination Vaccine Improves T-cell Priming and Enhances Immunity, Memory, and Tumor Elimination. Cancer Immunology Research. 4(9). 766–778. 20 indexed citations

14.

Hartman, Tracy L., Liyuan Yang, Matthew Hassink, et al.. (2016). Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus. Antiviral Research. 134. 216–225. 14 indexed citations

15.

Xi, Jiafei, Hong‐Hu Zhu, Daqing Liu, et al.. (2013). Infusion of Megakaryocytic Progenitor Products Generated from Cord Blood Hematopoietic Stem/Progenitor Cells: Results of the Phase 1 Study. PLoS ONE. 8(2). e54941–e54941. 27 indexed citations

16.

Vugmeyster, Yulia, John M. Harrold, & Xin Xu. (2012). Absorption, Distribution, Metabolism, and Excretion (ADME) Studies of Biotherapeutics for Autoimmune and Inflammatory Conditions. The AAPS Journal. 14(4). 714–727. 38 indexed citations

17.

Lin, Lin, Ashraf S. Ibrahim, Valentina Avanesian, et al.. (2009). Th17 Cells Are Not Required for Host Defense Against Murine Disseminated Candidiasis, But Are Required for Vaccine-Mediated Protection (132.10). The Journal of Immunology. 182(Supplement_1). 132.10–132.10. 1 indexed citations

18.

Vugmeyster, Yulia, et al.. (2009). Biodistribution of [125I]-labeled therapeutic proteins: Application in protein drug development beyond oncology**All authors are current or former employees of Wyeth, Inc.. Journal of Pharmaceutical Sciences. 99(2). 1028–1045. 43 indexed citations

19.

Glasson, S.S., et al.. (2008). In Vitro–In Vivo Correlation on Delivery of Drug Candidates to Articular Cartilage. Pharmaceutical Research. 25(7). 1641–1646. 5 indexed citations

20.

Chen, Jake Y., Allan Zajac, Sylvia A. McPherson, et al.. (2005). Primary adenovirus-specific cytotoxic T lymphocyte response occurs after viral clearance and liver enzyme elevation. Gene Therapy. 12(13). 1079–1088. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact